{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-156183","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.198343+00:00","generated_at":"2026-06-01T05:58:43.380960+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Royalty Pharma shareholders elect all eight directors at June 6 AGM; all proposals pass","bullets":["All eight director nominees elected with 457M–482M For votes; broker non-votes 24.8M per nominee.","Advisory say-on-pay approved (448.1M For, 37.7M Against); auditor Ernst & Young LLP ratified (510.5M For).","UK statutory accounts, directors' remuneration policy and report all passed with majority support.","Share allotment authorities (proposals 9 & 10) approved with over 455M For votes each.","Quorum of 85.49% of combined voting power represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-156183","json":"https://secwatch.observer/filing/0001193125-24-156183.json","markdown":"https://secwatch.observer/filing/0001193125-24-156183.md","text":"https://secwatch.observer/filing/0001193125-24-156183.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000119312524156183/0001193125-24-156183-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000119312524156183/d843058d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:58:43.380960+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}